ERLEADA® (apalutamide) Significantly Improved Overall Survival and Radiographic Progression-Free Survival in Patients with Metastatic HormoneSensitive Prostate Cancer
- EMEA Innovative Medicine
- ERLEADA® (apalutamide) Significantly Improved Overall Survival and Radiographic Progression-Free Survival in Patients with Metastatic HormoneSensitive Prostate Cancer
ERLEADA® (apalutamide) Significantly Improved Overall Survival and Radiographic Progression-Free Survival in Patients with Metastatic HormoneSensitive Prostate Cancer
- X (Twitter)
Copy link